According to data from the US Center for Disease Control and Prevention, the number of Johnson & Johnson Kovid-19 vaccine shots allocated by the federal government to states and other jurisdictions is expected to decline by 84% next week.
This week, about 5 million doses of the Johnson & Johnson vaccine were allocated to the states and other jurisdictions, but only 785,000 have been slated for the following week.
The allocation of Pfizer / BioNTech and Moderna vaccines for the next week, however, will be stable compared to this week. Approximately 4.7 million first doses of Pfizer and 3.5 million first doses of Modern have been allocated for the next week, along with a second second dose.
Pfizer / BioNTech and Moderna vaccines have been allocated largely from week to week. However, the weekly allocation for the Johnson & Johnson vaccine has varied widely.
According to CDC data, the first allocation of the Johnson & Johnson vaccine – for the week of March 1 – included more than 2.8 million doses. There is no allocation of the Johnson & Johnson vaccine for the week of March 8, and reduced the dose to at least 500,000 for two weeks. Then, for the week of March 29, the allocation increased to nearly 2 million before more than doubling this week.
According to CDS data, the total allocations for the Johnson & Johnson vaccine to states and other jurisdictions each week are:
- Week of 1 March: 2,833,400
- Week of 8 March: No one
- Week of 15 March: 493,700
- Week of 22 March: 389,900
- Week of March 29: 1,911,200
- Week of 5 April: 4,947,500
- Week of April 12: 785,500
According to the latest data from the CDC, approximately 4.5 million people have been vaccinated with the Johnson & Johnson vaccine, which is about 7% of those vaccinated in the US.